COLL Collegium Pharmaceutical Inc

Collegium Pharmaceutical Inc is a specialty pharmaceutical company which is engaged in developing and planning to commercialize abuse-deterrent products through its patented DETERx platform technology.

$16.00  +0.16 (1.01%)
As of 09/30/2022 15:59:56 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  05/07/2015
Outstanding shares:  34,126,205
Average volume:  257,259
Market cap:   $540,559,087
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BX7RSN3
Valuation   (See tab for details)
PE ratio:   12.78
PB ratio:   2.77
PS ratio:   1.98
Return on equity:   21.82%
Net income %:   15.68%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy